MUC1 drives epithelial-mesenchymal transition in renal carcinoma through Wnt/β-catenin pathway and interaction with SNAIL promoter

Cancer Letters

Volumn 346, Issue 2, 2014, Pages 225-236

  Gnemmi, Viviane ^a,b,c   Bouillez, Audrey ^a   Gaudelot, Kelly ^a   Hémon, Brigitte ^a   Ringot, Bélinda ^a   Pottier, Nicolas ^c,d   Glowacki, François ^b,c,d   Villers, Arnauld ^b,c   Vindrieux, David ^e   Cauffiez, Christelle ^c,d   Seuningen, Isabelle Van ^a   Bernard, David ^e   Leroy, Xavier ^a,b,c   Aubert, Sébastien ^a,b,c   Perrais, Michaël ^a,c  

^a INSERM   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c UNIV LILLE   (France)

^d France Institut Pasteur de Lille   (France)

^e CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

Author keywords

Beta catenin; Epithelial mesenchymal transition; GO 203; MUC1; SNAIL

Indexed keywords

BETA CATENIN; MESSENGER RNA; MUCIN 1; TRANSCRIPTION FACTOR SNAIL; CTNNB1 PROTEIN, HUMAN; MUC1 PROTEIN, HUMAN; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR; WNT PROTEIN;

ARTICLE; CANCER CELL; CELL NUCLEUS; CELLULAR DISTRIBUTION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SARCOMATOID CARCINOMA; TRANSACTIVATION; TRANSCRIPTION REGULATION; UPREGULATION; WNT SIGNALING PATHWAY; BIOSYNTHESIS; GENETICS; HEK293 CELL LINE; KIDNEY TUMOR; METABOLISM; PATHOLOGY; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

BETA CATENIN; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; CELL NUCLEUS; EPITHELIAL-MESENCHYMAL TRANSITION; HEK293 CELLS; HUMANS; KIDNEY NEOPLASMS; MUCIN-1; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84896140889     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.12.029     Document Type: Article

References (53)

1. Kufe D.W. MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches. Oncogene 2013, 32:1073-1081.
2. Kufe D.W. Mucins in cancer: function, prognosis and therapy. Nat. Rev. Cancer 2009, 9:874-885.
3. Leroy X., Copin M.C., Devisme L., Buisine M.P., Aubert J.P., Gosselin B., Porchet N. Expression of human mucin genes in normal kidney and renal cell carcinoma. Histopathology 2002, 40:450-457.
4. Aubert S., Fauquette V., Hémon B., Lepoivre R., Briez N., Bernard D., Van Seuningen I., Leroy X., Perrais M. MUC1, a new hypoxia inducible factor target gene, is an actor in clear renal cell carcinoma tumor progression. Cancer Res. 2009, 14:5707-5715.
5. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 2009, 119:1420-1428.
6. Sánchez-Tilló E., Liu Y., de Barrios O., Siles L., Fanlo L., Cuatrecasas M., Darling D.S., Dean D.C., Castells A., Postigo A. EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness. Cell Mol. Life Sci. 2012, 69:3429-3456.
7. Conant J.L., Peng Z., Evans M.F., Naud S., Cooper K. Sarcomatoid renal cell carcinoma is an example of epithelial-mesenchymal transition. J. Clin. Pathol. 2011, 64:1088-1092.
8. Boström A.K., Möller C., Nilsson E., Elfving P., Axelson H., Johansson M.E. Sarcomatoid conversion of clear cell renal cell carcinoma in relation to epithelial-to-mesenchymal transition. Hum. Pathol. 2012, 43:708-719.
9. Polyak K., Weinberg R.A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer 2009, 9:265-273.
10. Gilles C., Polette M., Mestdagt M., Nawrocki-Raby B., Ruggeri P., Birembaut P., Foidart J.M. Transactivation of vimentin by beta-catenin in human breast cancer cells. Cancer Res. 2003, 10:2658-2664.
11. Jing Y., Han Z., Zhang S., Liu Y., Wei L. Epithelial-mesenchymal transition in tumor microenvironment. Cell Biosci. 2011, 1.
12. Mikami S., Katsube K., Oya M., Ishida M., Kosaka T., Mizuno R., Mukai M., Okada Y. Expression of SNAIL and Slug in renal cell carcinoma: E-cadherin repressor SNAIL is associated with cancer invasion and prognosis. Lab Invest. 2011, 91:1443-1458.
13. Guaita S., Puig I., Franci C., Garrido M., Dominguez D., Batlle E., Sancho E., Dedhar S., De Herreros A.G., Baulida J. SNAIL induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. J. Biol. Chem. 2002, 18:39209-39216.
14. Roy L.D., Sahraei M., Subramani D.B., Besmer D., Nath S., Tinder T.L., Bajaj E., Shanmugam K., Lee Y.Y., Hwang S.I., Gendler S.J., Mukherjee P. MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition. Oncogene 2011, 30:1449-1459.
15. Ponnusamy M.P., Lakshmanan I., Jain M., Das S., Chakraborty S., Dey P., Batra S.K. MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells. Oncogene 2010, 29:5741-5754.
16. Rajabi H., Ahmad R., Jin C., Kosugi M., Alam M., Joshi M.D., Kufe D. MUC1-C oncoprotein induces TCF7L2 transcription factor activation and promotes cyclin D1 expression in human breast cancer cells. J. Biol. Chem. 2012, 287:10703-10713.
17. Perrais M., Chen X., Perez-Moreno M., Gumbiner B.M. E-cadherin homophilic ligation inhibits cell growth and epidermal growth factor receptor signaling independently of other cell interactions. Mol. Biol. Cell 2007, 6:2013-2025.
18. Schroeder J.A., Thompson M.C., Gardner M.M., Gendler S.J. Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland. J. Biol. Chem. 2001, 276:13057-13064.
19. Raina D., Kosugi M., Ahmad R., Panchamoorthy G., Rajabi H., Alam M., Shimamura T., Shapiro G.I., Supko J., Kharbanda S., Kufe D. Dependence on the MUC1-C oncoprotein in non-small cell lung cancer cells. Mol. Cancer Ther. 2011, 5:806-816.
20. Montross W.T., Ji H., McCrea P.D. A beta-catenin/engrailed chimera selectively suppresses Wnt signaling. J. Cell Sci. 2000, 113:1759-1770.
21. Vonica A., Weng W., Gumbiner B.M., Venuti J.M. TCF is the nuclear effector of the beta-catenin signal that patterns the sea urchin animal-vegetal axis. Dev. Biol. 2000, 217:230-243.
22. Chaika N.V., Gebregiworgis T., Lewallen M.E., Purohit V., Radhakrishnan P., Liu X., Zhang B., Mehla K., Brown R.B., Caffrey T., Yu F., Johnson K.R., Powers R., Hollingsworth M.A., Singh P.K. MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer. Proc. Natl. Acad. Sci. USA 2012, 109:13787-13792.
23. Sahraei M., Roy L.D., Curry J.M., Teresa T.L., Nath S., Besmer D., Kidiyoor A., Dalia R., Gendler S.J., Mukherjee P. MUC1 regulates PDGFA expression during pancreatic cancer progression. Oncogene 2012, 31:4935-4945.
24. Rajabi H., Alam M., Takahashi H., Kharbanda A., Guha M., Ahmad R., Kufe D. MUC1-C oncoprotein activates the ZEB1/miR-200c regulatory loop and epithelial-mesenchymal transition. Oncogene 2013, 10.1038/onc.2013.114.
25. Barberà M.J., Puig I., Domínguez D., Julien-Grille S., Guaita-Esteruelas S., Peiró S., Baulida J., Francí C., Dedhar S., Larue L., de Herreros A.García Regulation of SNAIL transcription during epithelial to mesenchymal transition of tumor cells. Oncogene 2004, 23:7345-7354.
26. Bouillez A., Butruille C., Ringot B., Gnemmi V., Van Seuningen I., Zini L., Leroy X., Aubert S., Perrais M. The MUC1 membrane-bound mucin is an actor in renal clear-cell carcinoma. Eur. J. Cancer 2012, 48:S84. (Meeting Abstract: 344).
27. Leng Y., Cao C., Ren J., Huang L., Chen D., Ito M., Kufe D. D. Nuclear import of the MUC1-C oncoprotein is mediated by nucleoporin Nup62. J. Biol. Chem. 2007, 282:19321-19330.
28. de Herreros A.García, Baulida J. Cooperation, amplification, and feed-back in epithelial-mesenchymal transition. Biochim. Biophys. Acta 2012, 1825:223-228.
29. Singh P.K., Behrens M.E., Eggers J.P., Cerny R.L., Bailey J.M., Shanmugam K., Gendler S.J., Bennett E.P., Hollingsworth M.A. Phosphorylation of MUC1 by Met modulates interaction with p53 and MMP1 expression. J. Biol. Chem. 2008, 283:26985-26995.
30. Leroy X., Zerimech F., Zini L., Copin M.C., Buisine M.P., Gosselin B., Aubert J.P., Porchet N. MUC1 expression is correlated with nuclear grade and tumor progression in pT1 renal clear cell carcinoma. Am. J. Clin. Pathol. 2002, 118:47-51.
31. Sung C.O., Choi H., Lee K.W., Kim S.H. Sarcomatoid carcinoma represents a complete phenotype with various pathways of epithelial mesenchymal transition. J. Clin. Pathol. 2013, 66:601-606.
32. Kovarik A., Peat N., Wilson D., Gendler S.J., Taylor-Papadimitriou J. Analysis of the tissue-specific promoter of the MUC1 gene. J. Biol. Chem. 1993, 268:9917-9926.
33. Stanisavljevic J., Porta-de-la-Riva M., Batlle R., de Herreros A.G., Baulida J. The p65 subunit of NF-κB and PARP1 assist SNAIL1 in activating fibronectin transcription. J. Cell Sci. 2011, 124:4161-4171.
34. Hu C.T., Chang T.Y., Cheng C.C., Liu C.S., Wu J.R., Li M.C., Wu W.S. SNAIL associates with EGR-1 and SP-1 to upregulate transcriptional activation of p15INK4b. FEBS J. 2010, 277:1202-1218.
35. Esteban M.A., Tran M.G., Harten S.K., Hill P., Castellans M.C., Chandra A., Raval R., O'brien T.S., Maxwell P.H. Regulation of E-cadherin expression by VHL and hypoxia-inducible factor. Cancer Res. 2006, 66:3567-3575.
36. Evans A.J., Russell R.C., Roche O., Burry T.N., Fish J.E., Chow V.W., Kim W.Y., Saravanan A., Maynard M.A., Gervais M.L., Sufan R.I., Roberts A.M., Wilson L.A., Betten M., Vandewalle C., Berx G., Marsden P.A., Irwin M.S., Teh B.T., Jewett M.A., Ohh M. VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and SNAIL. Mol. Cell Biol. 2007, 27:157-169.
37. Batlle E., Sancho E., Francí C., Domínguez D., Monfar M., Baulida J., de Herreros A.García The transcription factor SNAIL is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell Biol. 2000, 2:84-89.
38. Kovarik A., Lu P.J., Peat N., Morris J., Taylor-Papadimitriou J. Two GC boxes (Sp1 sites) are involved in regulation of the activity of the epithelium-specific MUC1 promoter. J. Biol. Chem. 1996, 271:18140-18147.
39. Zhou B.P., Deng J., Xia W., Xu J., Li Y.M., Gunduz M., Hung M.C. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat. Cell Biol. 2004, 10:931-940.
40. Yook J.I., Li X.Y., Ota I., Hu C., Kim H.S., Kim N.H., Cha S.Y., Ryu J.K., Choi Y.J., Kim J., Fearon E.R., Weiss S.J. A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells. Nat. Cell Biol. 2006, 12:1398-1406.
41. Stemmer V., de Craene B., Berx G., Behrens J. Snail promotes Wnt target gene expression and interacts with beta-catenin. Oncogene 2008, 37:5075-5080.
42. Yamamoto M., Bharti A., Li Y., Kufe D. Interaction of the DF3/MUC1 breast carcinoma-associated antigen and beta-catenin in cell adhesion. J. Biol. Chem. 1997, 272:12492-12494.
43. Huang L., Chen D., Liu D., Yin L., Kharbanda S., Kufe D. MUC1 oncoprotein blocks glycogen synthase kinase 3beta-mediated phosphorylation and degradation of beta-catenin. Cancer Res. 2005, 65:10413-10422.
44. Wesseling J., van der Valk S.W., Hilkens J. A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. Mol. Biol Cell 1996, 7:565-577.
45. Ligtenberg M.J., Buijs F., Vos H.L., Hilkens J. Suppression of cellular aggregation by high levels of episialin. Cancer Res. 1992, 52:2318-2324.
46. Carraway K.L., Ramsauer V.P., Haq B., Carothers Carraway C.A. Cell signaling through membrane mucins. Bioessays 2003, 25:66-71.
47. Sakai D., Tanaka Y., Endo Y., Osumi N., Okamoto H., Wakamatsu Y. Regulation of Slug transcription in embryonic ectoderm by beta-catenin-Lef/Tcf and BMP-Smad signaling. Dev. Growth Differ. 2005, 47:471-482.
48. Lambertini E., Franceschetti T., Torreggiani E., Penolazzi L., Pastore A., Pelucchi S., Gambari R., Piva R. SLUG: a new target of lymphoid enhancer factor-1 in human osteoblasts. BMC Mol. Biol. 2010, 3:11-13.
49. Behrens M.E., Grandgenett P.M., Bailey J.M., Singh P.K., Yi C.H., Yu F., Hollingsworth M.A. The reactive tumor microenvironment: MUC1 signaling directly reprograms transcription of CTGF. Oncogene 2010, 29:5667-5677.
50. Cascio S., Zhang L., Finn O.J. MUC1 protein expression in tumor cells regulates transcription of proinflammatory cytokines by forming a complex with nuclear factor-κB p65 and binding to cytokine promoters: importance of extracellular domain. J. Biol. Chem. 2011, 286:42248-42256.
51. Julien S., Puig I., Caretti E., Bonaventure J., Nelles L., van Roy F., Dargemont C., de Herreros A.G., Bellacosa A., Larue L. Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene 2007, 53:7445-7456.
52. Yin L., Kufe D. MUC1-C oncoprotein blocks terminal differentiation of chronic myelogenous leukemia cells by a ROS-mediated mechanism. Genes Cancer 2011, 2:56-64.
53. Raina D., Ahmad R., Rajabi H., Panchamoorthy G., Kharbanda S., Kufe D. Targeting cysteine-mediated dimerization of the MUC1-C oncoprotein in human cancer cells. Int. J. Oncol. 2012, 5:1643-1649.